Akihiko Iwai

4.3k total citations · 2 hit papers
38 papers, 3.5k citations indexed

About

Akihiko Iwai is a scholar working on Physiology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Akihiko Iwai has authored 38 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 11 papers in Cellular and Molecular Neuroscience and 10 papers in Molecular Biology. Recurrent topics in Akihiko Iwai's work include Alzheimer's disease research and treatments (11 papers), Neuroscience and Neuropharmacology Research (7 papers) and Prion Diseases and Protein Misfolding (5 papers). Akihiko Iwai is often cited by papers focused on Alzheimer's disease research and treatments (11 papers), Neuroscience and Neuropharmacology Research (7 papers) and Prion Diseases and Protein Misfolding (5 papers). Akihiko Iwai collaborates with scholars based in Japan, United States and United Kingdom. Akihiko Iwai's co-authors include Eliezer Masliah, Makoto Yoshimoto, Tsunao Saitoh, T Saitoh, Yu Xia, Nianfeng Ge, Lisa A. Flanagan, Ágnes Kittel, Kazumitsu Ueda and Yasuo Ihara and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neuron and Biochemistry.

In The Last Decade

Akihiko Iwai

37 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.

1993 1.2k citations Eliezer Masliah, Yu Xia et al. profile →
The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

1995 1.1k citations Akihiko Iwai, Eliezer Masliah et al. Neuron profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Akihiko Iwai Japan	16	2.4k	1.9k	1.3k	784	529	38	3.5k
Isaac Veinbergs United States	21	1.8k 0.7×	1.6k 0.9×	1.6k 1.2×	1.1k 1.3×	696 1.3×	25	3.7k
Ruth G. Perez United States	33	1.8k 0.8×	1.7k 0.9×	1.6k 1.2×	1.6k 2.1×	473 0.9×	56	4.2k
Alison L. McCormack United States	32	2.9k 1.2×	881 0.5×	2.1k 1.6×	1.5k 1.9×	732 1.4×	41	5.3k
Anita Sidhu United States	40	2.0k 0.8×	1.0k 0.6×	1.9k 1.4×	1.4k 1.8×	381 0.7×	86	4.0k
Amy Manning-Bog United States	19	1.9k 0.8×	947 0.5×	1.0k 0.8×	837 1.1×	494 0.9×	29	3.2k
Michael Mante United States	42	2.0k 0.8×	1.8k 1.0×	1.7k 1.3×	1.1k 1.4×	1.3k 2.4×	69	4.3k
Arianna Bellucci Italy	33	1.4k 0.6×	1.0k 0.6×	1.1k 0.8×	1.0k 1.3×	783 1.5×	72	3.2k
Jordi Bové Spain	24	2.1k 0.9×	946 0.5×	1.5k 1.1×	1.5k 1.9×	709 1.3×	35	4.3k
Tim Bartels United States	19	2.4k 1.0×	1.5k 0.8×	1.0k 0.8×	1.2k 1.5×	608 1.1×	30	3.6k
Christopher E. Ellis United States	6	1.4k 0.6×	751 0.4×	751 0.6×	614 0.8×	279 0.5×	7	2.2k

Countries citing papers authored by Akihiko Iwai

Since Specialization

Citations

This map shows the geographic impact of Akihiko Iwai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akihiko Iwai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akihiko Iwai more than expected).

Fields of papers citing papers by Akihiko Iwai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akihiko Iwai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akihiko Iwai. The network helps show where Akihiko Iwai may publish in the future.

Co-authorship network of co-authors of Akihiko Iwai

This figure shows the co-authorship network connecting the top 25 collaborators of Akihiko Iwai. A scholar is included among the top collaborators of Akihiko Iwai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akihiko Iwai. Akihiko Iwai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Iwai, Akihiko. (2011). [Gamma-secretase inhibitors and modulators].. PubMed. 69 Suppl 10 Pt 2. 83–7. 49 indexed citations

Terai, Kazuhiro, et al.. (2001). Apolipoprotein E deposition and astrogliosis are associated with maturation of β-amyloid plaques in βAPPswe transgenic mouse: Implications for the pathogenesis of Alzheimer’s disease. Brain Research. 900(1). 48–56. 28 indexed citations

Terai, Kazuhiro, Akihiko Iwai, Sueo Kawabata, et al.. (2001). β-amyloid deposits in transgenic mice expressing human β-amyloid precursor protein have the same characteristics as those in Alzheimer's disease. Neuroscience. 104(2). 299–310. 56 indexed citations

Iwai, Akihiko. (2000). Properties of NACP/α-synuclein and its role in Alzheimer’s disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1502(1). 95–109. 70 indexed citations

Kinoshita, Masao, et al.. (2000). Emergence of erosive polyarthritis coincident with Mycobacterium kansassi pulmonary infection in a patient with systemic sclerosis-rheumatoid arthritis overlap syndrome.. PubMed. 17(6). 757–8. 10 indexed citations

Ozono, S., Seung Cheol Kim, K. Takashima, et al.. (1999). [Intra-arterial chemotherapy for invasive bladder cancer].. PubMed. 45(2). 133–7. 3 indexed citations

Akiho, Hiraku, et al.. (1998). Neuroprotective Effect of YM-39558, Orotic Acid Ethylester, in Gerbil Forebrain Ischemia. The Japanese Journal of Pharmacology. 76(4). 441–444. 4 indexed citations

Akiho, Hiraku, et al.. (1997). Post-ischaemic treatment with orotic acid prevents neuronal injury in gerbil brain ischaemia. Neuroreport. 8(3). 607–610. 7 indexed citations

Xia, Yu, B.L. Rosi, Larry H. Yamaoka, et al.. (1996). Genetic studies in Alzheimer's disease with an NACP/α‐synuclein polymorphism. Annals of Neurology. 40(2). 207–215. 91 indexed citations

10.

Iwai, Akihiko, Eliezer Masliah, Mary Sundsmo, et al.. (1996). The synaptic protein NACP is abnormally expressed during the progression of Alzheimer' s disease. Brain Research. 720(1-2). 230–234. 44 indexed citations

11.

Iwai, Akihiko, Eliezer Masliah, Makoto Yoshimoto, et al.. (1995). The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron. 14(2). 467–475. 1097 indexed citations breakdown →

12.

Iwai, Akihiko, Makoto Yoshimoto, Eliezer Masliah, & Tsunao Saitoh. (1995). Non-A.beta. Component of Alzheimer's Disease Amyloid (NAC) is Amyloidogenic. Biochemistry. 34(32). 10139–10145. 186 indexed citations

13.

Suzuki, Masanori, et al.. (1995). Effect of YM796, a novel muscarinic agonist, on the impairment of passive avoidance response in senescence-accelerated mice. Pharmacology Biochemistry and Behavior. 51(4). 623–626. 11 indexed citations

14.

Hayakawa, Tetsushi, Nagao Shinagawa, Akihiko Iwai, et al.. (1991). A CASE OF PROGRESSIVE SYSTEMIC SCLEROSIS ASSOCIATED WITH GASTRIC CANCER. The journal of the Japanese Practical Surgeon Society. 52(9). 2098–2102. 1 indexed citations

15.

Miyata, K, Takeshi Kamato, Akito Nishida, et al.. (1991). Pharmacologic profile of (R)-5-[(1-methyl-3-indolyl)carbonyl]-4,5,6,7-tetrahydro-1H- benzimidazole hydrochloride (YM060), a potent and selective 5-hydroxytryptamine3 receptor antagonist, and its enantiomer in the isolated tissue.. Journal of Pharmacology and Experimental Therapeutics. 259(1). 15–21. 50 indexed citations

16.

Ozono, S., Yasuhiro Fukui, Akihiko Iwai, et al.. (1991). Neoadjuvant Therapy for Locally Invasive Bladder Cancer: Results of Randomized Trials in 40 Patients. Urologia Internationalis. 47(1). 116–119. 5 indexed citations

17.

Yamamoto, Minoru, et al.. (1989). Effects of indeloxamine hydrochloride on passive avoidance behavior of senescence-accelerated mice. European Journal of Pharmacology. 166(2). 345–348. 13 indexed citations

18.

Yura, Jiro, Nagao Shinagawa, Akira Mizuno, et al.. (1988). Cefotiam hexetil in the surgical field. Chemotherapy. 36. 694–702. 3 indexed citations

19.

Yamamoto, Masakazu, Masao Shimizu, & Akihiko Iwai. (1988). Antagonizing effects of YM-14673, a new TRH derivative, on behavioral and electroencephalographic changes in reserpinized animals. Psychopharmacology. 95(2). 162–6. 16 indexed citations

20.

Nishiyama, Nobuyoshi, et al.. (1985). Effect of Eleutherococcus senticosus and Its Components on Sex- and Learning-Behaviours and Tyrosine Hydroxylase Activities of Adrenal Gland and Hypothalamic Regions in Chronic Stressed Mice. 39(3). 238–242. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact